PRKAA1 and neoplasm: AMPK activation was observed by western blots using phospho-specific antibodies in the liver, spleen and tumours of mice treated or pre-treated with phenformin, consistent with a proposed mechanism of action of biguanides involving AMPK activation leading to mTORC1 inhibition (Zhang et al, 2007; Hadad et al, 2008).